GRI Bio (GRI)
NASDAQ:GRI
US Market
Holding GRI?
Track your performance easily

GRI Bio (GRI) Financial Statements

106 Followers

GRI Bio Financial Overview

GRI Bio's market cap is currently ―. The company's EPS TTM is $-98.353; its P/E ratio is >-0.01; GRI Bio is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.26M$ -1.89M$ -6.87M$ -2.41M$ -1.49M
EBITDA$ -2.26M$ -1.87M$ -4.74M$ -2.41M$ -1.49M
Net Income Common Stockholders$ -2.25M$ -1.89M$ -6.75M$ -2.40M$ -1.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.35M$ 4.09M$ 4.80M$ 1.67M$ 3.78M
Total Assets$ 7.03M$ 4.59M$ 5.64M$ 2.10M$ 4.15M
Total Debt$ 141.00K$ 152.00K$ 41.00K$ 0.00$ 0.00
Net Debt$ -6.21M$ -3.94M$ -4.76M$ -1.67M$ -3.78M
Total Liabilities$ 2.31M$ 1.79M$ 1.60M$ 1.88M$ 1.81M
Stockholders Equity$ 4.72M$ 2.80M$ 4.04M$ 216.00K$ 2.34M
Cash Flow-
Free Cash Flow$ -2.14M$ -2.20M$ -11.00K$ -2.12M$ -1.37M
Operating Cash Flow$ -2.14M$ -2.20M$ -3.00K$ -2.12M$ -1.37M
Investing Cash Flow--$ -8.00K-$ 420.00K
Financing Cash Flow$ 4.40M$ 4.49M$ 6.92M--
Currency in USD

GRI Bio Earnings and Revenue History

GRI Bio Debt to Assets

GRI Bio Cash Flow

GRI Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis